The Manila Times

Palisade Bio Appoints Leading Global IBD Experts, Laurent Peyrin-Biroulet, MD, PhD and David T. Rubin, MD, to Its Clinical Advisory Board

Internationally recognized leaders in inflammatory bowel disease bring deep expertise spanning ulcerative colitis, Crohn’s ...

Palisade Bio, Inc.: Palisade Bio Appoints Leading Global IBD Experts, Laurent Peyrin-Biroulet, MD, PhD and David T. Rubin, MD, to Its Clinical Advisory Board

Internationally recognized leaders in inflammatory bowel disease bring deep expertise spanning ulcerative colitis, Crohn's ...
Fierce Biotech

Sanofi keeps mum on future of disappointing Denali pact after scrapping final RIPK1 inhibitor

Sanofi is tight-lipped about the future of its underwhelming pact with Denali Therapeutics after the French pharma scrapped what appeared to be the final RIPK1 inhibitor from the deal. | Sanofi is ...
Zacks.com on MSN

TEVA's Q4 Earnings Beat, Branded Drugs Drive Revenue Growth

Teva Pharmaceutical Industries TEVA reported fourth-quarter 2025 adjusted earnings of 96 cents per share, which ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2025 earnings call transcript

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2025 Earnings Call Transcript January 28, 2026 Teva Pharmaceutical ...

Spyre Therapeutics Poised for Transformational 2026 With Six Expected Proof-of-Concept Readouts Beginning in Q2

(POC) readouts across SKYLINE and SKYWAY trials SKYLINE platform trial in ulcerative colitis (UC) recruiting faster than expected with SPY001 enrollment complete ahead of schedule; Part A readouts ...

You don’t just need more fiber—you need different types, experts say

From oats to beans to chicory root, each type of fiber acts differently inside the body. New research is revealing how fiber ...